A phase III study of PXL-01 for the prevention of post-surgical adhesions.
Phase of Trial: Phase III
Latest Information Update: 17 May 2017
At a glance
- Drugs PXL 01 (Primary)
- Indications Post-surgical adhesions
- Focus Therapeutic Use
- 17 May 2017 According to a ProMore Pharma media release, the company filed a clinical trial application with Drugs Controller General in India of for conducting a clinical study with patients undergoing tendon repair surgery after accidental flexor tendon transection.
- 02 Oct 2016 New trial record